Motley Fool Money cover image

Three Non-AI Stocks to Buy: MRK, UPS, CVX

Motley Fool Money

00:00

Merck's $9.2B Acquisition of Sidara (CDTX)

Karl explains Merck's all-cash purchase of Sidara for an influenza drug, premium paid, and strategic fit amid Keytruda's patent cliff.

Play episode from 01:03
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app